AMANDA SMALL: Open Payments
NPI 1588939714 · CENTENNIAL, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$702 in 26 payments from 13 companies in 2025. Trend: 2023 $1,502 · 2024 $502 · 2025 $702
Food & beverage: $702
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $148 |
| Exelixis Inc. | 3 | $105 |
| Merck Sharp & Dohme LLC | 3 | $85 |
| TerSera Therapeutics LLC | 3 | $75 |
| Genmab U.S., Inc. | 2 | $59 |
| Eisai Inc. | 2 | $46 |
| Caris MPI, Inc. | 1 | $36 |
| Daiichi Sankyo Inc. | 1 | $30 |
| Janssen Biotech, Inc. | 1 | $29 |
| Gilead Sciences, Inc. | 1 | $29 |
Products named: CABOMETYX, KEYTRUDA, Zoladex, Vyloy, Tivdak, Lenvima, Xospata, MI CANCER SEEK.
Industry payments across CO — which companies pay providers there.
